Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Algorae Says TGA Reviews Have Risen To Seven As First Customer Receipts Begin

1AI: $0.009 +0.00% · MC: $18M

At its AGM, Algorae Pharmaceuticals said seven product registrations are now under TGA review, up from five reported in its September-quarter update, and first customer receipts arrived during that quarter. The company also said its portfolio now exceeds 20 products and that first supply under its NSW Health arrangement is expected this quarter; shareholders passed all resolutions listed in the meeting results.

Source announcements: 2026-11-05 09:01 to 2026-11-05 13:53 Sydney time
Story updated 2026-11-05 13:58 Sydney time
SourcesAGM Chairman Address to ShareholdersResults of Meeting
Comments